Impact of intravenous thrombolysis prior to percutaneous coronary intervention in reperfusion therapy for acute myocardial infarction

Journal of Cardiology

Volumn 40, Issue 6, 2002, Pages 241-248

  Uto, Kenta ^b   Ota, Yoshimi ^a   Mizuno, Masayuki ^a   Nakamura, Ayako ^a   Nakajima, Ritsuko ^a   Endoh, Yasuhiro ^a   Kasanuki, Hiroshi ^b  

^a Saiseikai Kurihashi Hospital   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Interventional cardiology; Myocardial infarction, treatment; Reperfusion; Thrombolysis

Indexed keywords

CREATINE KINASE; FIBRINOLYTIC AGENT; MONTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; CREATINE KINASE BLOOD LEVEL; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; HEART BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REPERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION; TREATMENT OUTCOME; HEART INFARCTION; MIDDLE AGED; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0036984457     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ross AM, Coyne KS, Reiner JS, Greenhouse SW, Fink C, Frey A, Moreyra E, Traboulsi M, Racine N, Riba AL, Thompson MA, Rohrbeck S, Lundergan CF, for the PACT Investigators: A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: The PACT trial. J Am Coll Cardiol 1999; 34: 1954-1962
2. Kimura K, Tsukahara K, Usui T, Okuda J, Kitamura Y, Kosuge M, Sano T, Tohyama S, Yamanaka O, Yoshii Y, Umemura S: Low-dose tissue plasminogen activator followed by planned rescue angioplasty reduces time to reperfusion for acute myocardial infarction treated at community hospitals. Jpn Circ J 2001; 65: 901-906
3. Tsukahara K, Kimura K, Usui T, Okuda J, Kitamura Y, Kosuge M, Sano T, Tohyama S, Nemoto T, Yamanaka O, Yoshii Y, Tochikubo O, Umemura S: Efficacy of low-dose mutant tissue-type plasminogen activator followed by planned rescue percutaneous transluminal coronary angioplasty as reperfusion therapy for acute myocardial infarction. J Cardiol 2001; 37: 143-150 (in Jpn with Eng abstr)
4. Mukawa H, Sone T, Tsuboi H, Kondo J, Kosokabe T, Uesugi M, Imai H: Usefulness of combination therapy of hybrid thrombolysis followed by back-up percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction. J Cardiol 2001; 37: 181-189 (in Jpn with Eng abstr)
5. Feldman LJ, Himbert D, Juliard JM, Karrillon GJ, Benamer H, Aubry P, Boudvillain O, Seknadji P, Faraggi M, Steg G: Reperfusion syndrome: Relationship of coronary blood flow reserve to left ventricular function and infarct size. J Am Coll Cardiol 2000; 35: 1162-1169
6. Kobayashi N, Ohmura N, Nakada I, Yasu T, Iwanaka H, Kubo N, Katsuki T, Fujii M, Yaginuma T, Saito M: Further ST elevation at reperfusion by direct percutaneous transluminal angioplasty predicts poor recovery of left ventricular systolic function in anterior wall AMI. Am J Cardiol 1997; 79: 862-866
7. Miida T, Oda H, Toeda T, Higuma N: Additional ST-segment elevation immediately after reperfusion and its effect on myocardial salvage in anterior wall acute myocardial infarction. Am J Cardiol 1994; 73: 851-855
8. Yokoshiki H, Kohya T, Tateda K, Shishido T, Hirasawa K, Kitabatake A: Abrupt augmentation of ST segment elevation associated with successful reperfusion: A sign of diminished myocardial salvage. Am Heart J 1995; 130: 698-704
9. Kondo M, Tamura K, Tanio H, Shimono Y: Is ST segment re-elevation associated with reperfusion an indicator of marked myocardial damage after thrombolysis? J Am Coll Cardiol 1993; 21: 62-67
10. Matetzky S, Novikov M, Gruberg L, Freimark D, Feinberg M, Elian D, Novikov I, Di Segni E, Agranat O, Har-Zahav Y, Rabinowitz B, Kaplinsky E, Hod H: The significance of peristent ST elevation versus early resolution of ST segment elevation after primary PTCA. J Am Coll Cardiol 1999; 34: 1932-1938
11. Armstrong PW, Collen D: Fibrinolysis for acute myocardial infarction: Current status and new horizons for pharmacological reperfusion, part 1. Circulation 2001; 103: 2862-2866
12. Ishibashi F, Saito T, Hokimoto S, Noda K, Moriyama Y, Oshima S: Combined revascularization strategy for acute myocardial infarction in patients with intracoronary thrombus: Preceding intracoronary thrombolysis and subsequent mechanical angioplasty. Jpn Circ J 2001; 65: 251-256
13. Litt MR, Jeremy RW, Weisman HF, Winkelstein JA. Becker LC: Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia: Evidence for neutrophil-mediated reperfusion injury. Circulation 1989; 80: 1816-1827
14. Westlin W, Mullane KM: Alleviation of myocardial stunning by leukocyte and platelet depletion. Circulation 1989; 80: 1828-1836
15. The GUSTO investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-682
16. The GUSTO angiographic investigators: The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615-1622
17. Stone GW, Cox D, Garcia E, Brodie BR, Morice MC, Griffin J, Mattos L, Lansky AJ, O'Neill WW, Grines CL: Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: Analysis from the Primary Angioplasty in Myocardial Infarction trials. Circulation 2001; 104: 636-641
18. Topol EJ, Califf RM, George BS, Kereiakes DJ, Abbottsmith CW, Candela RJ, Lee KL, Pitt B, Stack RS, O'Neill WW, Thrombolysis and Angioplasty in Myocardial Infarction study group: A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Eng J Med 1987; 317: 581-588
19. Rogers WJ, Baim DS, Gore JM, Brown BG, Roberts R, Williams DO, Chesebro JH, Babb JD, Sheehan FH, Wackers FJ, Zaret BL, Robertson TL, Passamani ER, Ross R, Knatterud GL, Braunwald E, for the TIMI II-A Investigators: Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator: Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial. Circulation 1990; 81: 1457-1476
20. Califf RM, Topol EJ, Stack RS, Ellis SG, George BS, Kereiakes DJ, Samaha JK, Worley SJ, Anderson JL, Harrelson-Woodlief L, Wall TC, Phillips HR III, Abbottsmith CW, Candela RJ, Flanagan WH, Sasahara AA, Mantell SJ, Lee KL, for the TAMI study group: Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction: Results of thrombolysis and angioplasty in myocardial infarction: Phase 5 randomized trial. Circulation 1991; 83: 1543-1556
21. Gurbel PA, Serebruany VL, Shustov AR, Bahr RD, Carpo C, Ohman EM, Topol EJ, for the GUSTO-III investigators: Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment: Global Use of Strategies to Open Occluded Coronary Arteries. J Am Coll Cardiol 1998; 31: 1466-1473
22. Antman EM, Giugliano RP, Gibson M, McCabe CH, Coussement P, Kleiman NS, Vahanian A, Adgey AA, Menown I, Rupprecht HJ, Van der Wieken R, Ducas J, Scherer J, Anderson K, Van de Werf F, Braunwald E, for the TIMI 14 investigators: Abciximab facilitates the rate and extent of thrombolysis: Results of the thrombolysis in myocardial infarction (TIMI) 14 trial. Circulation 1999; 99: 2720-2732
23. Kosuge M, Kimura K, Ishikawa T, Endo T, Shimizu M, Hongo Y, Okuda J, Tochikubo O, Umemura S: Early peak creatine kinase activity is not always a marker of successful reperfusion with myocardial salvage in patients with reperfused anterior acute myocardial infarction. Am Heart J 2001; 141: 759-764
24. Braunwald E, Cannon CP, McCabe CH: An approach to evaluating thrombolytic therapy in acute myocardial infarction: The 'unsatisfactory outcome' end point. Circulation 1992; 86: 683-687
25. Danchin N, Vaur L, Genès N, Etienne S, Angioï M, Ferriéres J, Cambou JP: Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the "real world": One-year results from a nationwide French survey. Circulation 1999; 99: 2639-2644